with a better cosmetic outcome during the control visit 1 month later. Post-operative histopathological examination of the mass was considered to show juvenile papillomatosis ( Figure 2 ). Informed consent was obtained from the father of the patient who participated in this case.
Discussion and Conclusion
Juvenile papillomatosis is a clinicopathological entity first described by Rosen et al. This lesion, which causes a mass of the breast containing dilated ducts with some of them in papillary formations on macroscopic examination and cystic spaces, is similar to fibroadenoma. Microscopically, the main diagnostic criteria have been determined as papillary epithelial hyperplasia, ductal stasis, cysts with apocrine and non-apocrine epithelium, sclerosing adenosis, fibroadenomatoid hyperplasia and lobular hyperplasia (2) . In our patient, there were cystic spaces with lumens with single or several epitheliums located between the connective tissue elements, which appeared to be partially hyalinized. There were papillary formations in some of the cysts. No mitotic activity and necrosis was seen.
Juvenile papillomatosis is seen at the ages of 10 to 48 (average 23). It is seen equally in bilateral breasts. Although it is most commonly seen in the upper-outer quadrant, it has also been reported inferior to the areola. Its average dimension ranger from 1 to 8 cm. Based on Rosen's series of 180 cases, where the patients' menarche, parity, marital status and hormones were measured during pregnancy of the mother, no relationship was found between JP and endocrinological variations (3).
Our patient had not yet menstruated and the patient's mother did not take any medication during pregnancy.
When family members of patients with JP are questioned for breast diseases, breast carcinoma has been found to have a ratio of 58% in their first and second degree relatives. However, the presence of carcinoma in the relatives of patients with JP can be considered as a tumor marker of JP, allowing the possibility of following up their close relatives without waiting until they are over 50 years of age where the cancer risk is most (2) . No specific characteristics in terms of breast carcinoma were found in our patient's familial medical history. Bazzochi et al. (3) have found a familial history of breast carcinoma in 33% of patients with JP.
Patients present usually with the complaint of a mass in the breast regarding JP. Hemorrhagic discharge and pain of the nipple are rarely seen (4) . The reason of presentation of our patient was the presence of a single, unilateral and growing mass of the breast. In situ or invasive carcinoma at a ratio of 4% was diagnosed in the same or opposite breast regarding JP (5). During 59-to 274-month follow-up of patients with JP, breast carcinoma was diagnosed in 5 patients within about 14 years. In all of these patients, the lesion was bilateral with recurrence or multifocal and all patients had positive familial history (6).
Juvenile papillomatosis is a clinical entity different from childhood papillary ductus hyperplasia of the breast. Papillary ductus hyperplasia is commonly seen above 30 years of age. It has three types including intraductal papilloma, intraductal papillomatosis and sclerosing papillomatosis (7) . All characteristics such as the patient's age being below 30, identification of a mass with regular contours in the breast (although it is considered fibroadenoma in clinical setting), presence of ductal formations with some of them being cystic by dilation in the connective tissue areas on macroscopic examination, and the lumens of ducts containing partial papillary formations lined with epithelium that demonstrates single or several apocrine metaplasia are consistent with the diagnosis of juvenile papillomatosis as it was in our patient. In a 18 years of followup of patients with papillary ductal hyperplasia, carcinoma was found in none of them. However, when all the papillary lesions of the breast are considered, it is estimated that papillary carcinoma will emerge later on in 14% of the patients with papillomatosis in average (8) .
As patients affected by these lesions are usually young, US appears to be the optimal tool for their diagnosis and follow-up. Ultrasonography is useful for differentiating it from other cystic masses, fibroadenomas, intracystic papillomas, phyllodes tumors, and breast cancer. Although mammography is usually not routinely used for women younger than 35 years of age, its findings in rare cases that present include a homogenous opacity with sharp borders, which is also common in fibroadenomas and cysts. Magnetic resonance imaging also aids in the diagnosis by showing multiple small internal cysts on T2-weighted sequences (9) .
Treatment of juvenile papillomatosis is usually accomplished by complete excision followed by histologic confirmation. Prognosis is uncertain. No additional treatments are necessary if no carcinogenic lesions exist simultaneously. Recurrence is inevitable following incomplete excision. Annual monitoring for possible breast cancer development should be done until studies on this subject would determine the value of this practice. Breast carcinoma most commonly develops in those who had a family history for breast cancer and recurrent bilateral JP lesions (10). In conclusion, juvenile papillomatosis of the breast is rarely encountered in clinical practice. Although it is a benign lesion, monitoring of the patient and her family is an appropriate practice given that there is an association between family history and the risk of future development of breast cancer. In order to decrease the rate of recurrence, JP lesions should be excised completely.
Informed Consent: Informed consent was obtained from the father of the patient who participated in this study. 
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